Diseased Human Peripheral Blood Products, Hematological Cancer
Overview
Primary human plasma is isolated from peripheral blood using centrifugation. Primary human serum is isolated from peripheral blood after coagulation and removal of the fibrin clot and blood cells. All frozen peripheral blood products are obtained from donors diagnosed with a hematological cancer using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation to meet institutional requirements is available upon request. Acid-citrate-dextrose (ACD), acid-citrate-dextrose solution A (ACDA), citrate-phosphate-dextrose (CPD), citrate-phosphate-double-dextrose (CP2D), or citrate-phosphate-dextrose-adenine (CPDA) is added during collection as an anticoagulant.
Contact your local sales representative or Product & Scientific Support at techsupport@stemcell.com for donor specifications (BMI category, smoking status, ethnicity, etc.). Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C. Certain products are only available in select territories.
For more information, browse frequently asked questions (FAQs) on primary cells.
Scientific Resources
Product Documentation
Document Type | Product Name | Catalog # | Lot # | Language |
---|---|---|---|---|
Document Type
Product Information Sheet
|
Product Name
Hematological Cancer, Custom, Frozen
|
Catalog #
200-0404 |
Lot #
All |
Language
English |
Product Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Quality Statement:
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.